These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
831 related articles for article (PubMed ID: 29895321)
1. Neural stem cell therapy for subacute and chronic ischemic stroke. Boese AC; Le QE; Pham D; Hamblin MH; Lee JP Stem Cell Res Ther; 2018 Jun; 9(1):154. PubMed ID: 29895321 [TBL] [Abstract][Full Text] [Related]
2. Neural Stem Cells for Early Ischemic Stroke. Hamblin MH; Lee JP Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299322 [TBL] [Abstract][Full Text] [Related]
3. Human neural stem cells improve early stage stroke outcome in delayed tissue plasminogen activator-treated aged stroke brains. Boese AC; Eckert A; Hamblin MH; Lee JP Exp Neurol; 2020 Jul; 329():113275. PubMed ID: 32147438 [TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator followed by antioxidant-loaded nanoparticle delivery promotes activation/mobilization of progenitor cells in infarcted rat brain. Petro M; Jaffer H; Yang J; Kabu S; Morris VB; Labhasetwar V Biomaterials; 2016 Mar; 81():169-180. PubMed ID: 26735970 [TBL] [Abstract][Full Text] [Related]
5. Stem cells in stroke repair: current success and future prospects. Gopurappilly R; Pal R; Mamidi MK; Dey S; Bhonde R; Das AK CNS Neurol Disord Drug Targets; 2011 Sep; 10(6):741-56. PubMed ID: 21838668 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of brain ischemic stroke by co-transplantation of neural stem cells and endothelial progenitor cells]. Liu J; Mao B Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):204-8. PubMed ID: 17357472 [TBL] [Abstract][Full Text] [Related]
7. Pharmacologic management of ischemic stroke: relevance to stem cell therapy. Gilman S Exp Neurol; 2006 May; 199(1):28-36. PubMed ID: 16631744 [TBL] [Abstract][Full Text] [Related]
8. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Yepes M; Roussel BD; Ali C; Vivien D Trends Neurosci; 2009 Jan; 32(1):48-55. PubMed ID: 18963068 [TBL] [Abstract][Full Text] [Related]
9. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse. Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804 [TBL] [Abstract][Full Text] [Related]
10. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model. Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023 [TBL] [Abstract][Full Text] [Related]
11. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia. Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925 [TBL] [Abstract][Full Text] [Related]
12. Vascular protection and restorative therapy in ischemic stroke. Yamashita T; Deguchi K; Nagotani S; Abe K Cell Transplant; 2011; 20(1):95-7. PubMed ID: 20887680 [TBL] [Abstract][Full Text] [Related]
13. Long-lasting neuronal loss following experimental focal cerebral ischemia is not affected by combined administration of tissue plasminogen activator and hyperbaric oxygen. Hobohm C; Laignel F; Kacza J; Küppers-Tiedt L; Heindl M; Schneider D; Grosche J; Härtig W; Michalski D Brain Res; 2011 Oct; 1417():115-26. PubMed ID: 21914554 [TBL] [Abstract][Full Text] [Related]
14. Neural stem cell transplantation in ischemic stroke: A role for preconditioning and cellular engineering. Bernstock JD; Peruzzotti-Jametti L; Ye D; Gessler FA; Maric D; Vicario N; Lee YJ; Pluchino S; Hallenbeck JM J Cereb Blood Flow Metab; 2017 Jul; 37(7):2314-2319. PubMed ID: 28303738 [TBL] [Abstract][Full Text] [Related]
16. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke. Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413 [TBL] [Abstract][Full Text] [Related]
17. Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke. Sifat AE; Vaidya B; Abbruscato TJ AAPS J; 2017 Jul; 19(4):957-972. PubMed ID: 28484963 [TBL] [Abstract][Full Text] [Related]
18. Bystander Effect Fuels Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells to Quickly Attenuate Early Stage Neurological Deficits After Stroke. Eckert A; Huang L; Gonzalez R; Kim HS; Hamblin MH; Lee JP Stem Cells Transl Med; 2015 Jul; 4(7):841-51. PubMed ID: 26025980 [TBL] [Abstract][Full Text] [Related]
19. New progress in the approaches for blood-brain barrier protection in acute ischemic stroke. Li Y; Zhong W; Jiang Z; Tang X Brain Res Bull; 2019 Jan; 144():46-57. PubMed ID: 30448453 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator. Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]